BarryWilliamFestoffMD

PubMed

• 1 citations
  The evolving concept of neuro-thromboinflammation for neurodegenerative disorders and neurotrauma: A rationale for par1-targeting therapies
  Barry W. Festoff, Chris Dockendorff> ;Biomolecules. 2021 Oct 21
• 19 citations
  Thrombin and the Coag-Inflammatory Nexus in Neurotrauma, ALS, and Other Neurodegenerative Disorders.
  Barry W. Festoff, Bruce A. Citron> ;Frontiers in Neurology. 2019 Feb 5
• 3 citations
  Proximate Mediators of Microvascular Dysfunction at the Blood-Brain Barrier: Neuroinflammatory Pathways to Neurodegeneration
  Barry W. Festoff, Ravi K. Sajja, Luca Cucullo> ;Biomed Research International. 2017 Aug 14
• 105 citations
  HMGB1 and thrombin mediate the blood-brain barrier dysfunction acting as biomarkers of neuroinflammation and progression to neurodegeneration in Alzheimer’s disease
  Barry W. Festoff, Ravi K. Sajja, Patrick van Dreden, Luca Cucullo> ;Journal of Neuroinflammation. 2016 Aug 24
• 15 citations
  Membrane lipid peroxidation in neurodegeneration: Role of thrombin and proteinase-activated receptor-1
  Bruce A. Citron, Syed Ameenuddin, Koji Uchida, William Z. Suo, Karen SantaCruz, Barry W. Festoff> ;Brain Research. 2016 Jul 15
• 56 citations
  Mitochondrial lysates induce inflammation and Alzheimer's disease-relevant changes in microglial and neuronal cells.
  Heather M. Wilkins, Steven M. Carl, Sam G. Weber, Suruchi Ramanujan, Barry W. Festoff, Daniel A. Linseman, Russell H. Swerdlow> ;Journal of Alzheimer's Disease. 2015 Jan 1
• 30 citations
  Bioenergetic dysfunction and inflammation in Alzheimer's disease: a possible connection
  Heather M. Wilkins, Steven M. Carl, Alison C. S. Greenlief, Barry W. Festoff, Russell H. Swerdlow> ;Frontiers in Aging Neuroscience. 2014 Nov 10
• 4 citations
  Designing drugs that encourage spinal cord injury healing
  Barry W. Festoff> ;Expert Opinion on Drug Discovery. 2014 Sep 23
• 133 citations
  Microglial activation, increased TNF and SERT expression in the prefrontal cortex define stress-altered behaviour in mice susceptible to anhedonia
  Yvonne Couch, Daniel C. Anthony, Oleg V. Dolgov, Alexander Revischin, Barry W. Festoff, Ana Isabel Santos, Harry W.M. Steinbusch, Tatyana Strekalova> ;Brain, Behavior, and Immunity. 2013 Mar 1
• 44 citations
  Novel mutation in VCP gene causes atypical amyotrophic lateral sclerosis
  Paloma Gonzalez-Perez, Elizabeth T. Cirulli, Vivian E. Drory, Ron Dabby, P. Nisipeanu, R.L. Carasso, Menachem Sadeh, Andrew Fox, Barry W. Festoff, Peter C. Sapp, Diane...> ;Neurology. 2012 Nov 27
• 17 citations
  Soluble thrombomodulin levels in plasma of multiple sclerosis patients and their implication.
  Barry W. Festoff, Chaoyang Li, Barry Woodhams, Sharon G. Lynch> ;Journal of the Neurological Sciences. 2012 Dec 15
• 15 citations
  Neuroprotective effects of caspase-3 inhibition on functional recovery and tissue sparing after acute spinal cord injury
  Bruce A. Citron, Paul M. Arnold, Neal G. Haynes, Syed Ameenuddin, Mohammed Farooque, Karen S. SantaCruz, Barry W. Festoff> ;Spine. 2008 Oct 1
• 55 citations
  GRK5 deficiency leads to early Alzheimer-like pathology and working memory impairment
  Zhiming Suo, April A. Cox, Nicholas L. Bartelli, Imtiaz Rasul, Barry W. Festoff, Richard T. Premont, Gary W. Arendash> ;Neurobiology of Aging. 2007 Dec 1
• 28 citations
  Longitudinal magnetic resonance imaging of spinal cord injury in mouse: changes in signal patterns associated with the inflammatory response
  Mehmet Bilgen, Baraa Al-Hafez, Tareq Alrefae, Yong-Yu He, Irina V. Smirnova, M. M. Aldur, Barry W. Festoff> ;Magnetic Resonance Imaging. 2007 Jun 1
• 162 citations
  Minocycline neuroprotects, reduces microgliosis, and inhibits caspase protease expression early after spinal cord injury.
  Barry W. Festoff, Syed Ameenuddin, Paul Arnold, Andrea Wong, Karen S. SantaCruz, Bruce A. Citron> ;Journal of Neurochemistry. 2006 Jun 1
• 68 citations
  Gender-related differences in recovery of locomotor function after spinal cord injury in mice
  Mohammad Farooque, Suo Z, Arnold Pm, Wulser Mj, Chou Ct, Vancura Rw, Fowler S, Barry W. Festoff> ;Spinal Cord. 2006 Mar 1
• 29 citations
  Magnetic resonance imaging of mouse spinal cord
  Mehmet Bilgen, Baraa Al-Hafez, Nancy E.J. Berman, Barry W. Festoff> ;Magnetic Resonance in Medicine. 2005 Nov 1
• 10 citations
  Tissue transglutaminase during mouse central nervous system development: lack of alternative RNA processing and implications for its role(s) in murine models of neurot...
  Bruce A. Citron, Jamie E. Zoloty, Zhiming Suo, Barry W. Festoff> ;Brain Research. Molecular Brain Research. 2005 Apr 27
• 45 citations
  β-Synuclein Reduces Proteasomal Inhibition by α-Synuclein but Not γ-Synuclein
  Heather Snyder, Kwame Mensah, Cindy H. Hsu, Makoto Hashimoto, Irina Surgucheva, Barry W. Festoff, Andrei Surguchov, Eliazer Masliah, Andreas T Matouschek, Benjamin Wol...> ;The Journal of Biological Chemistry. 2005 Mar 4
• 18 citations
  Western ALS study group
  Robert G. Miller, Dan H. Moore, Carlayne E. Jackson, Deborah F. Gelinas, Richard J. Barohn, April McVey, Art Dick, David Saperstein, Jeffrey Rosenfeld, Mark B. Bromber...> ;Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders. 2004 Sep 1
• 19 citations
  Neuroprotective effects of recombinant thrombomodulin in controlled contusion spinal cord injury implicates thrombin signaling.
  Barry W. Festoff, Syed Ameenuddin, Karen SantaCruz, John Morser, Zhiming Suo, Paul Arnold, Kristie E. Stricker, Bruce A. Citron> ;Journal of Neurotrauma. 2004 Aug 25
• 50 citations
  Abnormality of G-protein-coupled receptor kinases at prodromal and early stages of Alzheimer's disease: an association with early beta-amyloid accumulation.
  Zhiming Suo, Min Wu, Bruce A. Citron, Gwendolyn T. Wong, Barry W. Festoff> ;The Journal of Neuroscience. 2004 Mar 31
• 50 citations
  Thrombin: a potential proinflammatory mediator in neurotrauma and neurodegenerative disorders.
  Z. Suo, Bruce A. Citron, Barry W. Festoff> ;Current Drug Targets. Inflammation and Allergy. 2004 Feb 29
• 76 citations
  Rapid tau aggregation and delayed hippocampal neuronal death induced by persistent thrombin signaling
  Zhiming Suo, Min Wu, Bruce A. Citron, Robert E. Palazzo, Barry W. Festoff> ;The Journal of Biological Chemistry. 2003 Sep 26
• 89 citations
  Persistent Protease-activated Receptor 4 Signaling Mediates Thrombin-induced Microglial Activation *
  Zhiming Suo, Min Wu, Bruce A. Citron, Chenhua Gao, Barry W. Festoff> ;The Journal of Biological Chemistry. 2003 Aug 15
• Join now to see all

Journal Articles

• Microglial activation, increased TNF and SERT expression in the prefrontal cortex define stress-altered behaviour in mice susceptible to anhedonia  
  Couch, Y., Anthony, D. C., Dolgov, O., Revischin, A., Festoff, B., Santos, A. I., Steinbusch, H. W. and Strekalova, T., Brain Behavior and Immunity, 3/2013
• Protein crosslinking, tissue transglutaminase, alternative splicing and neurodegeneration.  
  Citron, B.A., Suo, Z., SantaCruz, K.S., Davies, P.J. A., Qin, F. and. Festoff, B.W, Neurochem
• Spinal cord injury and neuronal cell death: apoptosis and implications for future treatment.  
  Citron B.A, Arnold, P.M., Ameenuddin, S. and Festoff, B.W, Sem
• Persistent protease- activated receptor 4 signaling mediates thrombin-induced microglial activation.  
  Suo, Z., Wu, M., Citron, B.A., Gao, C., Festoff, B.W, J Biol
• Proteinase-activated receptors in the nervous system: Roles in neuroplasticity and neurotrauma.  
  Festoff, B.W, Drug Dev
• Magnetic resonance imaging of mouse spinal cord.  
  Bilgen, M., Al-Hafez, B., Berman, N.E. and Festoff, B.W, Magn. Reson
• Novel mutation in VCP gene causes atypical amyotrophic lateral sclerosis.  
  González-Pérez, P., Cirulli, E.T., Drory, V.E., Dabby, R., Nisipeanu, P., Carasso, R.L., Sadeh, M., Fox, A., Festoff, B.W., Sapp, P.C., McKenna-Yasek, D., Goldstein,..., Neurology
• Soluble thrombomodulin levels in plasma of multiple sclerosis patients and their implication.  
  estoff, B.W., Li, C-Y, Woodhams, B., Lynch, S, J. Neurolog
• Role of thrombomodulin’s lectin-like domain in recovery after spinal cord injury in mice.  
  Vogeti, S., Chou, C-T, Conway, E.M. and Festoff, B.W, in review
• Transcriptional activity of neurodegeneration in cultured motor neurons and wobbler mice.  
  Citron B.A., Schramp, M., Wong, A., Ameenudin, S. and Festoff B.W, in review
• Upregulation of spinal cord dorsal horn proteinase-activated receptor 2 in neuroinflammatory pain models in rats.  
  Festoff, B.W., Oriti, L.A., McCarson, K. and Citron, B.A, in review
• In vitro studies of skeletal muscle membranes: Characterization of a phosphorylated intermediate of sarcolemmal (Na+ + K+) ATPase.  
  Reddy, N.B., Engel, W.K. And Festoff, B.W, Biochem
• Adenylate cyclase system of human skeletal muscle. Characteristics of catecholamine stimulation and nucleotide regulation.  
  Reddy, N.B., Oliver, K.L., Festoff, B.W. and Engel, W.K, Biochim. Biophys
• Adenylate cyclase system of human skeletal muscle. Subcellular distribution and general properties.  
  Reddy, N.B., Oliver, K.L., Festoff, B.W. and Engel, W.K, Biochim. Biophys
• Neurotrophic regulation of 16S acetylcholinesterase at the vertebrate neuromuscular junction  
  Fernandez, H.L., Duell, J.J., and Festoff, B.W, J. Neurobiol
• Insulin receptor on monocytes of MyD patients.  
  Festoff, B.W. and Moore, W.V., Jr, Trans. Am. Neurol. Assoc
• Circulating protease inhibitors in ALS: Reduced alpha-2- macroglobulin.  
  Festoff, B.W, Trans. Amer. Neurol. Assoc
• Trismus: A new sign in polymyositis.  
  Chikarmane, A., Singer, P.A. and Festoff, B.W, Trans. Amer. Neurol. Assoc
• amilial myasthenia with marked type II atrophy and negative antibody studies.  
  Chikarmane, A., Kepes, J., Singer, P.A. and Festoff, B.W, Trans. Amer. Neurol. Assoc
• Increased sensitivity to neuromuscular blockade in amyotrophic lateral sclerosis.  
  Chikarmane, A. and Festoff, B.W, Trans. Amer. Neurol. Assoc
• Phenytoin and the "safety margin" of neuromuscular transmission.  
  Franco, L.F. and Festoff, B.W, Trans. Amer. Neurol.Assoc
• Alpha 2-macroglobulin and plasma antiprotease activity (APA) in amyotrophic lateral sclerosis.  
  Festoff, B.W, Ann. NY Acad
• Appearance of acetylcholinesterase molecular forms in non-innervated cultured primary chick muscle cells.  
  Popiela, H., Beach, R.L. and Festoff, B.W, Molec. Neurobiol
• Production of extracellular matrix by cultured muscle cells: Characterization of media collagens of myoblasts.  
  each, R.L., Rao, J.S. and Festoff, B.W, Biochem. J
• Plasminogen activators and inhibitors: specific roles in neuromuscular regeneration.  
  Festoff, B.W. and Hantaï, D, Progr. Brain Res
• Join now to see all

Books/Book Chapters

• Roles in Development and Malignant and Degenerative Disease. 
  Chapter: Inhibitors in the Nervous System 
  Festoff, B.WEditors: Serine Proteases and Their Serpin.Plenum Press, New York
• Advances in Organ Biology. 
  Chapter: The Synapse in Development, Health and Disease 
  Festoff, B.WEditors: Hantaï, D. and Citron, B.A.JAI Press, GreenwichEdition 2,
• Pathogenesis of Human Muscular Dystrophies. 
  Chapter: Genetic alterations in surface membranes 
  Festoff, B.WEditors: L.P. Rowland. Excerpta Medica, Amsterdam
• Maturation of Neurotransmissio. 
  Chapter: Trophic effects of axonally transported proteins on muscle cells in culture 
  Page 152 - 158Festoff, B.W., Duell, M.J. and Fernandez, H.LEditors: A. Vernadakis, E. Giacobini and G. Filogamo.S.Karger, Base
• Current Topics in Nerve and Muscle Research, (A.J. Aguayo and G. Karpati. 
  Chapter: Role of cyclic nucleotides in skeletal muscle metabolism 
  Page 61 - 72Festoff, B.WEditors: A.J. Aguayo and G. Karpati. Excerpta Medica, Amsterdam
• Amyotrophic Lateral Sclerosis: Diagnosis and Treatment. 
  Chapter: Therapeutic trials in amyotrophic lateral sclerosis 
  Page 337 - 366Festoff, B.W. and Crigger, N.JEditors: D.M. Mulder.Houghton Mifflin, Boston
• Diabetic Neuropathy. 
  Chapter: Correlation of hemoglobin A1 and nerve conduction studies in diabetic patients 
  Page 331 - 335Singer, P.A., Festoff, B.W., Reeder, A.N., Spencer, L., Hassanein, K. and Hartman, CEditors: Y. Goto, A. Horiuchi and K. Kogure.Excerpta Medica, Amsterdam-Oxford
• Recent Advances in Clinical Therapeutics. 
  Chapter: Rational therapy in "untreatable" amyotrophic lateral sclerosis 
  Page 309 - 319Festoff, B.W., Perurena, O.H. and Singer, P.AEditors: J.Z. Yetiv and J.R. Bianchine.Grune and StrattonEdition 3,
• Neurology and Neurosurgery Update Series. 
  Chapter: Etiology and management of amyotrophic lateral sclerosis 
  Page 1 - 8Festoff, B.WEditors: P. Scheinberg and R.A. Davidof. CPEC, PrincetonEdition 4,
• Growth and Trophic Factors. 
  Chapter: Dose-dependent initiation of myogenesis by neurotrophic factor 
  Page 547 - 567Popiela, H., Ellis, S. and Festoff, B.WEditors: J.R. Perez-Polo, J. de Vellis and B. Haber.Alan R. Liss, New York
• Neuromuscular Diseases. 
  Chapter: Developmental appearance of acetylcholinesterase molecular forms in cultured primary chick muscle cells 
  Page 447 - 450Popiela, H., Beach, R.L., Festoff, B.WEditors: Serratrice, G., Cros, O., Desnuelle, C., Gastaut, J., Pellissier, J., Pouget, J., Schiano, A.Raven Press, New York
• Research Progress in Motor Neurone Diseases. 
  Chapter: Neural control of muscle acetylcholinesterase and its molecular forms: Relationship to diseases such as ALS 
  Page 290 - 303Popiela, H., Beach, R.L. and Festoff, B.WEditors: F.C. Rose.Pitman, London
• Research Progress in Motor Neurone Diseases. 
  Chapter: rophic factors and neuromuscular function: Implications for ALS 
  Page 228 - 248Beach, R.L., Popiela, H. and Festoff, B.WEditors: F.C. Rose.Pitman, London
• Research Progress in Motor Neuron Disease. 
  Chapter: Role of insulin receptors and insulin insensitivity in amyotrophic lateral sclerosis and related diseases 
  Page 263 - 275Reyes, E.T, Perurena, O.H., Festoff, B.W. and Popiela, HEditors: F.C. Rose.Pitman, London
• Research Progress in Motor Neurone Disease. 
  Chapter: Protocol for a model therapeutic trial in amyotrophic lateral sclerosis 
  Page 432 - 442Festoff, B.WEditors: F.C. Rose.Pitman, London
• Cholinesterase - Fundamental and Applied Aspects. 
  Chapter: Neurocrine regulation of acetylcholinesterase in health and disease 
  Page 317 - 330Festoff, B.W., Popiela, H., Beach, R.LEditors: M. Brzin, E.A. Barnard and D. Sket.Walter de Gruyter, Berlin
• Molecular Neurobiology. 
  Chapter: Plasminogen activator in muscle, its activation post-denervation 
  Page 162 - 166Festoff, B.W., Hantaï, D., Soria, C., Soria, J. and Fardeau, MEditors: Levi-Montalcini, R., Calissano, P., Kandel, E. and Maggi, A.Springer- Verlag, Berlin
• Molecular Neurobiology. 
  Chapter: Muscle adhesive basement membrane proteins are degraded by plasminogen activator in the presence of plasminogen 
  Page 167 - 171Hantaï, D. and Festoff, B.WEditors: Levi-Montalcini, R., Calissano, P., Kandel, E. and Maggi, A.Springer-Verlag, Berlin
• The Spinal Cord. 
  Chapter: Amyotrophic lateral sclerosis: The syndrome, its pathophysiology and approach to treatment 
  Page 607 - 664Festoff, B.WEditors: R.A. Davidoff.Marcel Dekker, New YorkEdition 5,
• Encyclopedia of Neuroscience. 
  Chapter: Muscular Dystrophies, dystrophies 
  Page 723 - 724Festoff, B.W. and Rao, J.SEditors: Adelman, G.Birkhauser, Boston
• Realities in Coping with Progressive Neuromuscular Diseases. 
  Chapter: The decision-making process in amyotrophic lateral sclerosis 
  Cobb, A.C., Hamera, E. and Festoff, B.WEditors: Charash, L.I., Lovelace, R.E., Wolf, S.G., Kutscher, A.H., Roye, D.P. and Leach, C.F.The Charles Press, Philadelphia, PA
• Advances in Neuromuscular Diseases. 
  Chapter: Therapeutic trial of recombinant human growth hormone in amyotrophic lateral sclerosis 
  Page 117 - 126Festoff, B.W., Melmed, S., and Smith, R.AEditors: Serratrice, G., Pellissier, J-F., Desnuelle, C. and Pouget, J.Expansion Scientifique Française, Paris
• Progress in Clinical Trials. Amyotrophic Lateral Sclerosis. 
  Chapter: The future of clinical trials in amyotrophic lateral sclerosis: the recombinant era 
  Page 1 - 14Festoff, B.WEditors: F.C. Rose.Demos Publications, New York
• Progress in Clinical Trials. Amyotrophic Lateral Sclerosis. 
  Chapter: The influence of compliance and other human factors on treatment trials 
  Page 45 - 52Smith, R.A., Jacoby, S. and Festoff, B.W., Peterson, L., Melmed, S., Molnar, G., Sherman, B. and Frane, JEditors: F.C. Rose.Demos Publications, New York
• Serine Proteases and Their Serpin Inhibitors in the Nervous System: Roles in Development and Malignant and Degenerative Disease. 
  Chapter: Plasminogen activators in development, injury and pathology of the neuromuscular system 
  Page 219 - 228Hantaï, D., Soria, C., Soria, J., Blondet, B., Barlovatz-Meimon, G., Rao, J.S. and Festoff, B.WEditors: Festoff, B.W.Plenum Press, New York
• Join now to see all

Abstracts/Posters

• Muscle- derived thrombin elicits axon retraction and death in motor neurons through direct and indirect signal mechanisms.
  Popovik, E., Haynes, L.W., Festoff, B.W., Citron, B.A. and Heywood, D, Federation of European Neuroscience Sociteies, Brighton, UK
• Neurotrophic regulation of 16S muscle end-plate acetylcholinesterase.
  Fernandez, H.L., Duell, M.J. and Festoff, B.W, IVth International Congress on Neuromuscular Diseases, Montreal
• In vivo evidence of potential pathogenetic role of tissue transglutaminase (tTG) in Lewy body (LB) formation and neuronal degeneration.
  Suo, Z., SantaCruz, K., Meredith, G.E., Petroske, E., Lau, Y-S, Citron, B.A and Festoff, B, Neurosci
• Presence of 16S acetylcholinesterase in neural tissue and its bi-directional transport.
  Festoff, B.W., Duell, M.J.and Fernandez, H.L, IVth International Congress on Neuromuscular Diseases, Montreal
• Alternatively- spliced sequences of tissue transglutaminase (tTG) in Alzheimer's disease (AD) brains.
  Citron, B. A., SantaCruz, K., Zoloty, J., Suo, Z. and Festoff, B. W, Neurosci
• Recombinant human thrombomodulin (TM, Solulin) improves recovery after spinal cord injury (SCI).
  Festoff, B. W., Ameenuddin, S., Morser, J., Citron, B. A., Malladi, S., Brobst, D. and Arnold, P. M, Neurosci
• Prolonged exposure to alpha thrombin inhibits capacitive calcium entry in hippocampal astrocytes.
  Vignes, M., Festoff, B.W., Aubert, M. and Guiramand J, Neurosci
• Bi-directional axonal transport of macromolecular (16S) acetylcholinesterase.
  Festoff, B.W. and Fernandez, H.L, Neurosci
• Caspase inhibition for prevention of cell death following spinal cord injury.
  Arnold, P.M., Ameenuddin, S., Citron, B. A., Malladi, S., Brobst, D. and Festoff, B.W, Neurosci
• Cellular distribution of 16S acetylcholinesterase in mammalian tissues.
  Duell, M.J., Fernandez, H.L., and Festoff, B.W, Neurosci
• Behavioral, morphological, and molecular correlations in an alternative mouse model of parkinsonism showing progressive dopaminergic neurodegeneration.
  Petroske, E., Meredith, G.E., Callen, S., Totterdell, S., Festoff, B.W., Citron, B.A. and Lau, Y-S, Neurosci
• Developmental appearance of acetylcholinesterase molecular forms in chick muscle culture.
  Patterson, M.R., Fernandez, H.L.and Festoff, B.W, Neurosci
• Neurotrophic control of 16S acetylcholinesterase at the neuromuscular junction.
  Fernandez, H.L. and Festoff, B.W, Neurosci
• Two parameter cell sorting of chick spinal cord motor neurons.
  Piper, S.T. and Festoff, B.W, Neurochem
• Gene therapy and protease inhibition in neurodegeneration: transfection of motor neurons (MNs) with protease nexin I (PNI).
  Dalal, R., Samson, F.E., Suo, Z., Citron, B.A., Landis, M., Graeser, R. and Festoff, B.W, Neurosci
• Microglia express functional thrombin receptor, protease-activated receptor-1 (PAR-1).
  Suo, Z., Wu, M., Ameenuddin, S., Anderson, H., Zoloty, J.E., Citron, B.A. and Festoff, B.W, Neurosci
• Two parameter cell sorting of dissociated chick spinal cord.
  Piper, S.T. and Festoff, B.W, Cell Tissue Kinet
• Release of plasminogen activator from cultured muscle cells.
  Patterson, M.R., Romstedt, K. and Festoff, B.W, Neurosci
• Basement membrane (BM) collagen (Type IV) metabolism at neuromuscular junctions.
  Romstedt, K. and Festoff, B.W, Neurosci
• Distribution and localization of collagenase in skeletal muscle.
  Festoff, B.W., Romstedt, K. and Piper, S.T, Neurosci
• Correlation of receptor capacity, affinity and in vivo tissue insulin sensitivity in myotonic dystrophy (MyD).
  Perurena, O.H., Moore, W.V. and Festoff, B.W, Neurology
• Receptor binding and affinity: Role in insulin resistance in myotonic dystrophy.
  Festoff, B.W., Perurena, O.H. and Moore, W.V, Clin. Res
• Plasminogen activator and protease nexin in myogenesis.
  Festoff, B.W., Patterson, M.R., Eaton, D. and Baker, J.B, J. Cell. Biol
• Metabolism of substrate-attached material during myogenesis in vitro.
  Beach, R.L., Patterson, M.R., Hendricks, W.J., Hower, J.A. and Festoff, B.W, J. Cell. Biol
• Effect of neutral and lysosomal protease inhibitors on acetylcholine receptor (AChR) turnover in cultured muscle.
  Romstedt, K., Beach, R.L. and Festoff, B.W, Fed. Proc
• Join now to see all